SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-21-000004
Filing Date
2021-01-04
Accepted
2021-01-04 08:33:11
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 immunovants-3.htm S-3 826125
2 EX-1.2 exhibit12-sx3.htm EX-1.2 302690
3 EX-4.3 exhibit43-sx3.htm EX-4.3 406280
4 EX-4.5 exhibit45-sx3.htm EX-4.5 133153
5 EX-4.6 exhibit46-sx3.htm EX-4.6 144222
6 EX-4.7 exhibit47-sx3.htm EX-4.7 119956
7 EX-5.1 exhibit51-sx3.htm EX-5.1 37749
8 EX-23.1 exhibit231-sx3.htm EX-23.1 2253
9 cooleylogo1a.jpg GRAPHIC 45127
10 image_22.jpg GRAPHIC 35648
11 immunovantlogo2.jpg GRAPHIC 13770
  Complete submission text file 0001628280-21-000004.txt   2100607
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-251865 | Film No.: 21500285
SIC: 2836 Biological Products, (No Diagnostic Substances)